November 7, 2022

Paxlovid may reduce risk of long covid in eligible patients, study finds

The research looked at patients who qualified for the antiviral drug because of their age or medical condition. Those who took it soon after infection were 26 percent less likely to have symptoms 90 days later. Source link
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more